Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Dries Reynders

Awards & Distinctions

25 Results

2025

Factors associated with statural growth in pediatric kidney transplant recipients with focus on metabolic acidosis

Agnieszka Prytula-EbelsDries ReyndersEls GoetghebeurKai KrupkaJustine BacchettaNele KanzelmeyerIsabella GuzzoRaffaella LabbadiaElisa BenettiMohan Shenoy et al.

A1 Journal Article in PEDIATRIC NEPHROLOGY

2024

Budget impact projections for pharmaceuticals

Irina OdnoletkovaDries ReyndersFrederik De KeersmaekerStephan DevrieseEls GoetghebeurIrina Cleemput

PEACE V—Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : acute toxicity of a randomized phase 2 trial

Piet OstShankar SivaSigmund BrabrandPiet DirixNick LiefhoogheFrançois-Xavier OtteAlfonso Gomez-IturriagaWouter EveraertsMohamed ShelanAntonio Conde-Moreno et al.

A1 Journal Article in EUROPEAN UROLOGY ONCOLOGY

The role of the estimand framework in the analysis of patient-reported outcomes in single-arm trials: a case study in oncology

Doranne ThomassenSatrajit RoychoudhuryCecilie Delphin AmdalDries ReyndersJammbe Z. MusoroWilli SauerbreiEls GoetghebeurSaskia le Cessie[ missing ] on behalf of the SISAQOL-IMI Work Package 3

A1 Journal Article in BMC MEDICAL RESEARCH METHODOLOGY

2023

Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial

Mathieu SpaasNora SundahlVibeke KruseSylvie RotteyDaan De MaeseneerFréderic DuprezYolande LievensVeerle SurmontLieve BrochezDries Reynders et al.

A1 Journal Article in JAMA ONCOLOGY

2022

PEACE V - STORM randomized phase II trial for oligorecurrent nodal prostate cancer : acute toxicity

T. ZilliS. SivaR. HeikkilaP. DirixN. LiefhoogheF. OtteA. Gomez-IturriagaW. EveraertsM. ShelanA. Conde-Moreno et al.

Phase I study of intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for unresectable peritoneal metastases

Wim CeelenLouis SandraLeen Van de SandeM GraversenMB MortensenAn VermeulenElke GasthuysDries ReyndersSarah CosynsAnne Hoorens et al.

A1 Journal Article in EBIOMEDICINE

2021

Challenges encountered when evaluating an antibody-detecting point-of-care test for taeniosis in an endemic community in Zambia : a prospective diagnostic accuracy study

Chishimba MubangaChiara TrevisanInge Van DammeVeronika SchmidtIsaac K. PhiriGideon ZuluJohn NohSukwan HandaliRichard MamboMwelwa Chembensofu et al.

A1 Journal Article in DIAGNOSTICS

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Mathieu SpaasNora SundahlEva HulstaertVibeke KruseSylvie RotteyDaan De MaeseneerVeerle SurmontAnnabel MeiresonLieve BrochezDries Reynders et al.

A1 Journal Article in BMC CANCER

Evaluation of an antibody detecting point of care test for diagnosis of Taenia solium cysticercosis in a Zambian rural community : a prospective diagnostic accuracy study

Chishimba MubangaInge Van DammeChiara TrevisanVeronika SchmidtIsaac K. PhiriGideon ZuluJohn NohSukwan HandaliRichard MamboMwelwa Chembensofu et al.

A1 Journal Article in DIAGNOSTICS

Intraperitoneal aerosolized nanoparticle albumin based paclitaxel (NAB-PTX) for irresectable peritoneal metastases : a first in human phase I study

Wim CeelenLouis SandraLeen Van de SandeMartin GraversenAn VermeulenDries ReyndersSarah CosynsAnne HoorensWouter Willaert

Prognostic value of high-risk human papillomavirus DNA and p16(INK4)(a) immunohistochemistry in patients with anal cancer : an individual patient data meta-analysis

Theresa ObermuellerJoris HautekietMaria Paula BustoDries ReyndersLiliana BelgioiaAnnemieke CatsDuncan C. GilbertStefan A. KoerberSabine MaiDidier Meulendijks et al.

A1 Journal Article in EUROPEAN JOURNAL OF CANCER

The multicenter, randomized, phase 2 PEACE V-STORM trial : defining the best salvage treatment for oligorecurrent nodal prostate cancer metastases

Thomas ZilliPiet DirixReino HeikkilaNick LiefhoogheShankar SivaAlfonso Gomez-IturriagaWouter EveraertsFrancois OtteMohamed ShelanCarole Mercier et al.

Editorial material

2020

PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM) : a study protocol for a randomized controlled phase II trial

Aurélie De BruyckerAn SpiessensP. DirixN. KoutsouvelisI. SemacN. LiefhoogheA. Gomez-IturriagaW. EveraertsF. OtteA. Papachristofilou et al.

A1 Journal Article in BMC CANCER

2019

Metastasis-directed therapy in treating nodal oligorecurrent prostate cancer : a multi-institutional analysis comparing the outcome and toxicity of stereotactic body radiotherapy and elective nodal radiotherapy

Elise De BleserBarbara Alicja Jereczek-FossaDavid PasquierThomas ZilliNicholas Van AsAndrei FodorPiet DirixAlfonso Gomez-IturriagaFabio TrippaShankar Siva et al.

A1 Journal Article in EUROPEAN UROLOGY

Prognostic significance of number versus location of positive mesenteric nodes in stage iii colon cancer

Kozo KataokaHannes YsebaertManabu ShiozawaDries ReyndersMasataka IkedaNaohiro TomitaEls GoetghebeurWim Ceelen

A1 Journal Article in EJSO

Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results

Piet OstNora SundahlG VandekerkhoveKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls Goetghebeur et al.

Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma

Nora SundahlGillian VandekerkhoveKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls GoetghebeurJo Van Dorpe et al.

A1 Journal Article in EUROPEAN UROLOGY

Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results

Gillian VandekerkhoveNora SundahlKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls GoetghebeurJo Van Dorpe et al.

2018

Phase 1 dose escalation trial of ipilimumab and stereotactic body radiation therapy in metastatic melanoma

Nora SundahlKatrien De WolfVibeke KruseAnnabel MeiresonDries ReyndersEls GoetghebeurMireille Van GeleReinhart SpeeckaertBenjamin HennartLieve Brochez et al.

A1 Journal Article in INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Reply to J.-E. Bibault et al, B. Tombal, and C. Cattrini et al

Piet OstDries ReyndersKarel DecaesteckerValerie FonteyneNicolaas LumenBieke LambertLouke DelrueGert De Meerleer

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence : a prospective, randomized, multicenter phase II trial

Piet OstDries ReyndersKarel DecaesteckerValerie FonteyneNicolaas LumenAurélie De BruyckerBieke LambertLouke DelrueRenée BultijnckTom Claeys et al.

A1 Journal Article in JOURNAL OF CLINICAL ONCOLOGY

2017

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response

Nora SundahlKatrien De WolfSylvie RotteyKarel DecaesteckerDaan De MaeseneerAnnabel MeiresonEls GoetghebeurValerie FonteyneSofie VerbekePieter De Visschere et al.

A1 Journal Article in JOURNAL OF TRANSLATIONAL MEDICINE

Harmonization of serum thyroid-stimulating hormone measurements paves the way for the adoption of a more uniform reference interval

Linda ThienpontKatleen Van UytfangheLinde De GrandeDries ReyndersBarnali DasJames D. FaixFinlay MacKenzieBrigitte DecallonneAkira HishinumaBruno Lapauw et al.

A1 Journal Article in CLINICAL CHEMISTRY

Standardization of free thyroxine measurements allows the adoption of a more uniform reference interval

Linde De GrandeKatleen Van UytfangheDries ReyndersBarnali DasJames D. FaixFinlay MacKenzieBrigitte DecallonneAkira HishinumaBruno LapauwPaul Taelman et al.

A1 Journal Article in CLINICAL CHEMISTRY